DPP4 and obesity due to melanocortin 4 receptor deficiency: Plasma DPP4 activity was associated with the development of obesity, type 2 diabetes, and type 1 diabetes using animal models; in particular streptozotocin (STZ) is commonly used to induce type 1 and late-phase type 2 diabetic models by selective β-cell destruction in small rodents.